Study of immune therapies for hard-to-treat inflammatory diseases
Part of Immune system & allergy clinical trials.
This study follows patients with inflammatory or autoimmune diseases that are not well controlled by standard treatments. Researchers want to learn how safe and effective new immune-modulating medications are when they are tried next.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have an inflammatory or autoimmune disease that is still active despite standard treatments, and your doctor recommends a new therapy.
- You are enrolled in the French national social security system.
- You are not pregnant or breastfeeding, and if you could become pregnant, a negative pregnancy test is required.
- You do not have active tuberculosis (latent TB being treated is okay), severe immune problems, recent live vaccines, cancer in the last 5 years, or severe kidney or liver issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to understand the immune system in people who have immune problems or whose immune-related diseases are not helped by standard treatments. It may lead to better ways to diagnose and treat these conditions.
This study looks at blood “biomarkers,” or measurable body signals, in people with autoimmune diseases, vasculitis, or autoinflammatory conditions. The goal is to better understand these illnesses and how they relate to disease activity.
This trial tests a new type of medicine (ABO2203) that trains your immune system to attack the cells causing your autoimmune disease. It's for people who haven't gotten better with standard treatments.
This study measures blood “biomarkers” (signals in blood) to better understand inflammatory diseases, including autoimmune and autoinflammatory conditions. You may be asked to give blood samples now and possibly extra samples if needed for testing.
This study looks at how the immune system works in people with rare autoinflammatory diseases. The goal is to develop tests that can help doctors better understand and treat these conditions.
This study looks at how chronic inflammatory illnesses progress over time and how treatments affect symptoms and disease markers. You may be invited if you’re receiving care for certain bowel, joint, or skin inflammatory conditions at the hospital.
Hear when a new Autoimmune Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.